会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 10. 发明申请
    • FACTOR IXA INHIBITORS
    • 因子IXA抑制剂
    • WO2014120346A1
    • 2014-08-07
    • PCT/US2013/075233
    • 2013-12-16
    • MERCK SHARP & DOHME CORP.MOCHIDA PHARMACEUTICAL CO., LTD.SMITH, Cameron, JamesTAN, John, QiangZHANG, TingBALKOVEC, JamesGREENLEE, William, JohnGUO, LiangqinXU, JiayiCHEN, Yi-hengCHEN, YiliCHACKALAMANNIL, SamuelHIRABAYASHI, TomokazuNAGASUE, HiroshiOGAWA, Kouki
    • SMITH, Cameron, JamesTAN, John, QiangZHANG, TingBALKOVEC, JamesGREENLEE, William, JohnGUO, LiangqinXU, JiayiCHEN, Yi-hengCHEN, YiliCHACKALAMANNIL, SamuelHIRABAYASHI, TomokazuNAGASUE, HiroshiOGAWA, Kouki
    • A61K31/5377C07D413/12
    • C07D413/14C07D417/14C07D471/04C07D487/04C07D498/04
    • The present invention provides a compound of Formula (I) (structurally represented) wherein R1 is H or C1-6 alkyl, R2 is H or C1-6 alkyl or CH20H, R3 is H or C1-6 alkyl, and R4 is H or C1-6 alkyl, provided that when R1, R2, and R3 are H, R4 is C1-6 alkyl, and when R1, R2, and R4 are H, then R3 is C1-6 alkyl, and when R1, R3, and R4 are H, R2 is C1-6 alkyl or-CH20H, and when R2, R3, and R4 are H, then R1 is C 1-6 alkyl; A is 1 ) a 9-10 membered bicyclic heterocycle having 1-3 heteroatoms independently selected from N, S and 0, which 9-10 membered bicyclic heterocycle is unsubstituted or substituted with R5 and unsubstituted or substituted with R6 and unsubstituted or substituted with NH2, or 2) a 6-9 membered monocyclic or bicyclic carbocyclic ring system unsubstituted or substituted with R5, unsubstituted or substituted with R6, and unsubstituted or substituted with -CH2NH2; and B is 1) a 5- or 6-membered monocyclic heterocycle having 1 or 2 heteroatoms independently selected from N, S or 0, which is unsubstituted or substituted on a carbon or nitrogen atom with R7, unsubstituted or substituted on a carbon or nitrogen atom with R8, and unsubstituted or substituted on a carbon or nitrogen atom with R9, or 2) an 8- or 9-membered fused bicyclic heterocycle having 1, 2 or 3 nitrogen atoms which is unsubstituted or substituted on a carbon or nitrogen atom with R7, and unsubstituted or substituted on a carbon or nitrogen atom with R8; and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses.
    • 本发明提供式(I)(结构上表示)的化合物,其中R 1是H或C 1-6烷基,R 2是H或C 1-6烷基或CH 2 OH,R 3是H或C 1-6烷基,R 4是H或 C 1 -C 6烷基,条件是当R 1,R 2和R 3为H时,R 4为C 1-6烷基,并且当R 1,R 2和R 4为H时,R 3为C 1-6烷基,并且当R 1,R 3和 R 4是H,R 2是C 1-6烷基或-CH 2 OH,当R 2,R 3和R 4是H时,R 1是C 1-6烷基; A是1)具有1-3个独立地选自N,S和0的杂原子的9-10元双环杂环,其中9-10元双环杂环是未取代的或被R5取代,未被取代或被R6取代,未被取代或被NH 2取代 ,或2)未被取代或被未取代或被R 6取代的R 5取代的未取代或被-CH 2 NH 2取代的6-9元单环或双环碳环系统; 和B为1)具有1或2个独立地选自N,S或0的杂原子的5或6元单环杂环,其未被取代或在碳或氮原子上被取代或未取代或在碳或氮上取代的R7取代 具有R 8的未取代或取代的碳原子或氮原子上的取代基,或2)具有1,2或3个氮原子的8或9元稠合双环杂环,其未被取代或在碳原子或氮原子上被取代, R7,并且在碳或氮原子上未被取代或取代为R8; 和包含一种或多种所述化合物的药物组合物,以及使用所述化合物治疗或预防血栓形成的方法。